Bicalutamide plus Aromatase Inhibitor in Patients with Estrogen Receptor‐Positive/Androgen Receptor‐Positive Advanced Breast Cancer

LESSONS LEARNED: Studies targeting the androgen receptor (AR) signaling pathway in aromatase inhibitor (AI)‐resistant breast cancer are limited. Bicalutamide, one of the commonly used AR inhibitors in prostate cancer, in combination with AI, did not show synergistic activity in patients with estroge...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Lu, Qianyi, Xia, Wen, Lee, Kaping, Zhang, Jingmin, Yuan, Huimin, Yuan, Zhongyu, Shi, Yanxia, Wang, Shusen, Xu, Fei
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6964139/
https://ncbi.nlm.nih.gov/pubmed/31434793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0564
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados